Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News
Disclaimer
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
BioPharmaJournal
Home
Contact Us
About Us
Advertise
Biotech
Aclaris Therapeutics (ACRS): Strategic Alliance with Biosion Ignites 53% Stock Surge
Sintx Technologies, Inc. (SINT): A Bold Move with Strategic Stock Repurchase…
HCW Biologics Inc. (HCWB): A Strategic Leap with Worldwide Licensing Agreement…
Viking Therapeutics (VKTX): Is This Weight Loss Drug Contender Worth Buying…
RadNet, Inc. (RDNT): Strategic Collaboration with GE HealthCare Boosts Stock by…
Finance
Singular Genomics (OMIC) Surges Over 65% Following recent Acquisition Proposal from…
Monte Rosa Therapeutics Soars on Novartis Deal: A Molecular Glue Revolution
Betforward: A Gateway to Sports Betting and Online Gaming
Aligos Therapeutics ($ALGS): A Bold Move to Regain Nasdaq Compliance
Portage Biotech Inc. (NASDAQ: PRTG): A Closer Look at a Tumultuous…
Tech News
Aehr Test Systems (NASDAQ: AEHR) Receives an Order of $10.8 Million…
Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
Micro and Macro Tailwinds Converge for KULR
ISWH and the Rebirth of the Crypto Cycle
Disclaimer
Home
Tags
MacroGenics Inc. (NASDAQ:MGNX)
Tag: MacroGenics Inc. (NASDAQ:MGNX)
MacroGenics Inc. (NASDAQ:MGNX) Reports Its Q3 Financial Results and Clinical Updates...
Ward Sport
-
November 20, 2020
0
MacroGenics Inc. (NASDAQ:MGNX) Announce Publication Of Research Supporting flotetuzumab Study in...
Kate Hudson
-
June 11, 2020
0
MacroGenics Inc. (NASDAQ:MGNX) Gives Update OnBLA Review for Margetuximab In Treating...
Kate Hudson
-
June 4, 2020
0
Recent Post
Aclaris Therapeutics (ACRS): Strategic Alliance with Biosion Ignites 53% Stock Surge
Ash K
-
November 18, 2024
0
Aclaris Therapeutics, Inc. (NASDAQ: ACRS) experienced a remarkable 53.17% spike in its stock price, closing at $3.14 on November 18, 2024, following...
Sintx Technologies, Inc. (SINT): A Bold Move with Strategic Stock Repurchase...
November 18, 2024
HCW Biologics Inc. (HCWB): A Strategic Leap with Worldwide Licensing Agreement...
November 18, 2024
Viking Therapeutics (VKTX): Is This Weight Loss Drug Contender Worth Buying...
November 11, 2024
RadNet, Inc. (RDNT): Strategic Collaboration with GE HealthCare Boosts Stock by...
November 11, 2024
romabet
mahbet
پین باهیس
bettingmagazine.org
بت کارت
یاس بت
yekbet
megapari
onjabet
alvinbet
betboro
betfa
بت فوروارد
1xbet
1win
betwinner
4shart.com
1xbetgiris.cam
وان کیک بت
وین بت
ریتزوبت
1xbet-ir.com.co
وان ایکس بت
بت فوروارد